Previous Article | Next Article ![]()
Mol Cell Biol, March 1998, p. 1534-1543, Vol. 18, No. 3
Department of Biochemistry and Molecular
Biology, SUNY Health Science Center at Syracuse, Syracuse, New York
13210
Received 14 August 1997/Returned for modification 24 September
1997/Accepted 10 December 1997
Mutants of Saccharomyces cerevisiae that lack vacuolar
proton-translocating ATPase (V-ATPase) activity show a well-defined set
of Vma
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutations in the Yeast KEX2 Gene Cause a
Vma
-Like Phenotype: a Possible Role for the Kex2
Endoprotease in Vacuolar Acidification
(stands for vacuolar membrane ATPase activity)
phenotypes that include pH-conditional growth, increased calcium
sensitivity, and the inability to grow on nonfermentable carbon
sources. By screening based on these phenotypes and the inability of
vma mutants to accumulate the lysosomotropic dye quinacrine
in their vacuoles, five new vma complementation groups
(vma41 to vma45) were identified. The
VMA45 gene was cloned by complementation of the
pH-conditional growth of the vma45-1 mutant strain and
shown to be allelic to the previously characterized KEX2
gene, which encodes a serine endoprotease localized to the late Golgi
compartment. Both vma45-1 mutants and kex2 null
mutants exhibit the full range of Vma
growth phenotypes
and show no vacuolar accumulation of quinacrine, indicating loss of
vacuolar acidification in vivo. However, immunoprecipitation of the
V-ATPase from both strains under nondenaturing conditions revealed no
defect in assembly of the enzyme, vacuolar vesicles isolated from a
kex2 null mutant showed levels of V-ATPase activity and
proton pumping comparable to those of wild-type cells, and the V-ATPase
complex purified from kex2 null mutants was structurally indistinguishable from that of wild-type cells. The results suggest that kex2 mutations exert an inhibitory effect on the
V-ATPase in the intact cell but that the ATPase is present in the
mutant strains in a fully assembled state, potentially capable of full enzymatic activity. This is the first time a mutation of this type has
been identified.
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biology, SUNY Health Science Center at
Syracuse, 750 E. Adams St., Syracuse, NY 13210. Phone: (315) 464-8742. Fax: (315) 464-8750. E-mail:
kanepm{at}vax.cs.hscsyr.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»